Beijing Noahpharm Co., Ltd. is a wholly-funded subsidiary of the publicly traded company Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (stock code: 688621). With a registered capital of RMB 10 million, Beijing Noahpharm Co., Ltd. is a CRO to provide the professional clinical trial solution for pharmaceutical and medical device manufacturers. The company owns a powerful clinical medical & registration team, superior clinical site resources, a well-established quality assurance system, and an experienced clinical monitoring and project operation team. The company provides all-round technical services for pharmaceutical and medical device manufacturers and relevant R&D institutions, and uses its high quality and efficient services to help customers shorten R&D period, address technical difficulties and cut R&D cost. Noahpharm has established four professional platforms: clinical trial R&D platform (governing two R&D platforms of medical and clinical operation), data management and statistical analysis platform, SMO platform, third-party audit platform; provides systemic professional support for clinical trial operation to reduce the project R&D risk, helps customers save R&D fund, speeds up the industrialized conversion of the project, and continuously empowers corporate development. Relying on many local clinical trial institutions, Noahpharm has established an experienced operation team and an expert group with profound professional background, and owns rich clinical trial experience with innovative drugs and 505b(2), which covers the clinical design and trial operation of drugs and medical devices in therapeutic areas of oncology, cardiovascular system, neurology, endocrinology, anti-infection, analgesia, and rare diseases. Over years of extension, expansion and improvement of the upstream and downstream industry chain, Noahpharm is dedicated to building an integrated and multi-round clinical service platform of drugs and medical devices, providing a one-stop solution for customers and securing human health and welfare.